Module title: Therapeutic Options for Malignant Haematological Disorders (Theory)

SCQF level: 11:
SCQF credit value: 20.00
ECTS credit value: 10

Module code: NMS11130
Module leader: Emma Trotter
School School of Health & Social Care
Subject area group: Cancer Collaborative
Prerequisites

n/a

2019/0, Trimester 2, Blended,
Occurrence: 003
Primary mode of delivery: Blended
Location of delivery: SIGHTHILL
Partner:
Member of staff responsible for delivering module: Emma Trotter
Module Organiser:


Learning, Teaching and Assessment (LTA) Approach:
This module encourages you to learn independently through your participation in a range of VLE based activities within Moodle and Webinar facilities with support from your academic supervisor and peer group. You will critically reflect on the literature relevant to the pathophysiology of disease and its treatment in relation to your clinical practice (LO1-2). You will participate in discussion boards and Webinars with other colleagues to enhance deeper learning on specific subjects and encourage collaboration and networking (LO 3). The VLE materials have been designed to provide you with autonomy on the how and when you learn. By this we mean there are a variety of learning approaches taken for example – reflection on; case studies, suggested reading and listening to audio and video material (LO 4, 5).
Embedding of employability/PDP/Scholarship Skills
This module will combine traditional intellectual and analytical skills with reflective skills. The use of Moodle and Webinar facilities contributes towards core transferable skills in information technology and group participation over the Internet. The course is seen as important assets to the East of Scotland Haematology Nursing Group, the RCN Nursing Society of Haematological Nurses and holds importance within clinical practice due to an organisational commitment linking education of nursing staff (Band 6 and 7) and accreditation to perform patient care. The assignments have been developed and designed to aid the student in enhancing clinical practice by looking at treatment and research in depth. The student can also use the content of the course in application of their knowledge toward their personal development plans and knowledge skills framework in the core domains and the Health and Wellbeing domains (HWB3, 4, 5, 6 and 7).


Formative Assessment:
Formative Assignment
Formative assessment takes the form of quizzes, and online Tutorials within Moodle, summative assessment feedback (LO1- 6).



Summative Assessment:
Summative assignment
The students should
• Write an article (2000 words), for a journal of your choice, on a new treatment for a haematological disease incorporating the implications for your professional role in administration of the treatment. (40%).
• Identify a research or clinical service issue affecting patient care within your area of practice, critically review within the context of global and national research/service priorities, and present your findings in a report (2,000 words ) (40%).
• Provide a reflective account in learning log format of new learning and relevance to clinical practice of discussion board participation and Blackboard collaborate (1000) (20%).


Student Activity (Notional Equivalent Study Hours (NESH))
Mode of activityLearning & Teaching ActivityNESH (Study Hours)
Online Guided independent study 190
Online Groupwork (Scheduled) 4
Online Lecture 6
Total Study Hours200
Expected Total Study Hours for Module200


Assessment
Type of Assessment Weighting % LOs covered Week due Length in Hours/Words
Essay 100 1,2,3,4,5 28 HOURS= 0, WORDS= 3500
Component 1 subtotal: 100
Component 2 subtotal: 0
Module subtotal: 100

Description of module content:

The module starts by refreshing students’ knowledge of blood physiology, chemotherapy, radiotherapy, nutrition, virology, immunology and bacteriology. Placing haematology in the context of cancer care.
The module is then divided into 2 sections Unit 1b, which covers Leukaemia’s, Lymphomas, and Myeloma, including new novel treatments, clinical trials and complications of treatment.
Unit 2 which, covers transplantation and transplant complications Psychosocial issues of treatment, survivorship and ethical implications, the multidisciplinary team approach, family involvement, donor issues, emergency care and end of life issues.

Learning Outcomes for module:

Upon completion of this module you will be able to:
LO1 Evaluate haematological patho-physiology and epidemiology in relation to clinical practice.
LO2. Critically explore the treatment options and outcomes for an individual, undergoing chemotherapy, radiotherapy, immune therapy, bone marrow or peripheral stem cell transplant.
LO3. Critically engage with the psychosocial, ethical, and end of life implications for a person in relation to treatment.
LO4. Evaluate the importance of the role of the health professional within the multidisciplinary team.
LO5. Appraise developments in evidence-based practice and the potential of these to inform current clinical practice.

Indicative References and Reading List - URL:

Please contact your Module Leader for details
Click here to view the LibrarySearch.